TRANSDERMAL DELIVERY OF FLUCONAZOLE MICROSPONGES: PREPARATION AND IN VITRO CHARACTERIZATION by Dineshmohan, S & Gupta, V Rama Mohan
Dineshmohan et al                                                    Journal of Drug Delivery & Therapeutics. 2016; 6(6):7-15                         7 
© 2011-16, JDDT. All Rights Reserved                                            ISSN: 2250-1177                                                    CODEN (USA): JDDTAO 
 
Available online on 15.11.2016 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open access to Pharmaceutical and Medical research 
© 2016, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
noncommercial use, provided the original work is properly cited 
 
Research Article 
TRANSDERMAL DELIVERY OF FLUCONAZOLE MICROSPONGES: PREPARATION 
AND IN VITRO CHARACTERIZATION  
S. Dineshmohan
1*
, V. Rama Mohan Gupta
2 
1*Department of Pharmaceutics, Vishnu Institute of Pharmaceutical Education and Research, Narsapur 502313, Hyderabad, 
Telangana, INDIA 
2Department of Pharmaceutics, Pullareddy Institute of Pharmacy, Annaram, Hyderabad, Telangana, INDIA 
___________________________________________________________________________________________________________ 
ABSTRACT 
The pivotal objective of this investigation was to formulate Fluconazole microsponge by emulsion solvent diffusion technique in order to 
provide sustained release. Microsponge was formulated by emulsion solvent diffusion technique with varied drug–polymer ratios. Ethyl 
cellulose was used as release retarding material and polyvinyl alcohol was used as a surfactant. The prepared microsponges were 
characterized by Scanning electron microscopy, Fourier transform infrared spectroscopy, particle size analysis, and evaluated for surface 
morphology, drug loading, in vitro drug release as well. The formulated microsponges are spherical with a porous surface and 108.16μm of 
mean particle size. The microsponges were then incorporated into the carbopol gel. The In vitro drug release results showed that 
microsponges with 1:1.5 drug–polymer ratios were more effective to make a prolonged drug release of 74.2% at the end of 8 hours. Thus the 
formulated microsponge-based gel of fluconazole would be a hopeful choice for formal therapy for safe and effective treatment of fungal 
infections. 
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INTRODUCTION 
Fluconazole is a synthetic antifungal agent belonging to 
the group of triazole. It is one of the commonly used 
antifungal agents for most kinds of fungal infections; 
including superficial and invasive fungal infections. 
1 
Regrettably fluconazole oral administration has 
limitations such as nausea, vomiting, bloating and 
abdominal discomfort. Alongside most of the time the 
parenteral administration of fluconazole led to skin 
rashes and itching. 
2 For these reasons, now a day’s 
advance localized and transdermal delivery has gained a 
lot of importance. 
3,4
  
The conventional gel formulation of fluconazole causes 
cutaneous irritation and prolonged use led to dermal 
hypersensitivity.  Hence, a novel system necessitates 
which will increase the presence of active agents either 
on the skin surface or within the epidermis, concurrently 
reducing hasty transdermal penetration. Many 
researchers have attempted to develop novel transdermal 
formulations of fluconazole. Accordingly, the objective 
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of our research is to formulate and evaluate fluconazole 
microsponge loaded carbopol gel for safe, effective and 
stable gel and evaluate the in-vitro sustained release 
performance. Microsponge-based delivery systems 
(MDS) give assurance of drug legalization on the skin 
surface and within the epidermis without entering into 
the systemic circulation in greater extent; thereby 
reducing systemic and local cutaneous adversities. They 
also offer an advantage of programmable release and are 
biologically safe. Additionally, this technology presents 
quite a lot of benefits via drug entrapment by means of 
better formulation flexibility, abridged side effects, 
improved elegance and superior stability.
5-8
  
MATERIALS AND METHODS 
Materials 
Fluconazole was obtained as a gift sample from RMS 
Research labs Pvt Ltd Hyderabad. Ethyl cellulose was 
gifted by Yeluri formulations, Hyderabad.  Polyvinyl 
alcohol, triethyl citrate and ethyl acetate were purchased 
from Emerck (India) Ltd., Mumbai. All other chemicals 
and solvents used are of analytical grade. 
Methods  
Formulation of Fluconazole microsponge 
Fluconazole loaded microsponges were prepared by 
quasi-emulsion solvent diffusion technique
9
. The 
internal phase was encompassed ethyl cellulose and 
triethylcitrate (TEC) both were dissolved in 10ml of 
ethyl acetate. TEC was used as plasticizer. This was, 
followed by addition of fluconazole with stirring. The 
internal phase was then poured into polyvinyl alcohol 
(PVA) solution in water, the external phase. Then the 
final mixture was filtered through filter paper with a 
pore size of 0.45 µm to separate formed microsponges 
and dried at room temperature for further studies. 
Calculation of production yield, actual drug content 
and entrapment efficiency  
The production yield (PY) was determined by following 
formula accurately calculating the initial weight of the 
raw materials and the weight of the obtained 
microsponge particles. Samples of drug loaded 
microsponges (20 mg) were dissolved in 10 ml 
phosphate buffer pH 5.5 under sonication for 20 min at 
25°C. The samples were filtered using 0.45 µm 
membrane filter and analyzed for FLZ content 
spectrophotometrically using Shimadzu UV-1650 UV–
VIS double beam spectrophotometer (Shimadzu, Japan) 
at 260 nm. The actual drug content and EE were 
calculated as given below.
10, 11
 
The actual drug content (%) = (Mact / Mms) x 100  
The EE (%) was calculated according to the following 
equation:  
Entrapment efficiency = (Mact /Mthe) x 100  
Where Mact is the actual fluconazole content with 
weighed quantity of the microsponge, Mms is the 
weighed quantity of powder of microsponges, and Mthe 
is the theoretical amount of fluconazole in microsponge 
calculated from the quantity added during preparation. 
All the experiments were performed in triplicate and the 
mean of the values was reported. 
Particle size analysis  
Particle size analysis of prepared microsponges was 
carried out using particle size analyzer (Malvern 
Mastersizer Hydro 2000, Ver.5.54 Malvern, UK) which 
allows sample measurement in the range of 0.020–2000 
mm and the particle refractive index were set to 1.520.  
Microsponges were dispersed in double distilled water 
before running the sample in instrument to ensure that 
light scattering signal (as indicated by particle count per 
second) is within the sensitivity range of the 
instrument
12
. 
Fourier Transform Infrared studies  
IR spectra of the pure drug, other excipients and 
formulations were obtained and compared. In the 
present study, potassium bromide (KBr) pellet method 
was employed. The samples were thoroughly mixed 
with dry powder of potassium bromide and scanned 
from 4000-400cm
-1
 by FT-IR spectrophotometer (Model 
number 02437 Shimadzu, India) 
13 
Scanning electron microscopy studies  
The morphology and appearance of the microsponges 
were studied using SEM (SEM-JEOL Instrument, JSM- 
6360, Japan) operating at 15 KV. The samples were 
dusted onto double-sided tape on a metal stub and 
coated with gold/palladium alloy under vacuum. The 
obtained photograph was recorded at x500 
magnification
14
. 
Formulation of fluconazole microsponge gel  
To obtain a suitable topical formulation for application, 
microsponges were incorporated into a gel base. After 
the preliminary tests carbopol was found to be an ideal 
choice. 0.5 g of Carbopol 934 was uniformly dispersed 
in beakers containing a sufficient quantity of water and 
was allowed to hydrate overnight. Then it was mixed 
with 5 g of glycerin with methyl paraben to form a 
paste. Next, 95 ml of water was added slowly to paste 
under constant stirring, followed by the drop wise 
Triethanolamine addition to adjust pH to 6.5–7.5. A 
calculated amount of FLZ microsponge was 
incorporated which makes the final concentration of 
fluconazole in the gel is 1% w/w
15
. 
Evaluation of microsponge loaded carbopol gel  
Homogenicity  
The prepared gels were visually inspected for clarity, 
color and transparency. The prepared gels were also 
evaluated for the presence of any particles. Smears of 
gels were prepared on a glass slide and observed under 
the microscope for the presence of any particle or 
grittiness
16, 17
. 
pH  
The pH of the prepared fluconazole loaded microsponge 
gel was measured using pH – meter (LI-120 Digital PH 
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Meter) by putting the tip of the electrode into the gel and 
after 2 minutes the result was recorded
16, 17
. 
Spreadability  
A sample of 0.1g of gel was pressed between 2 slides 
with 500g weights and left for about 5 min where no 
more spreading was expected. Diameters of spread 
circles were measured in cm and were taken as 
comparative values for spreadability (diameter of the 
spread circle – initial diameter16, 17. 
S=ML /T  
Where M = weight (in g) attached to upper 
slide, L = length (in cm) of glass slides, and  
T = time (in s) taken to separate the slides. 
Wooden block-glass slide apparatus was used and by 
applying weight about 20 g, time for complete 
separation of the upper slide (movable) from a lower 
slide (fixed) was estimated 
Viscosity  
The viscosity of fluconazole loaded microsponge 
carbopol gel was measured in Brookfield Viscometer, 
model- VL2 (Lemis Baltic) with spindle No 4
16, 17
. 
In vitro drug release  
The in vitro release of gel formulations was studied 
using Franz diffusion cells. The cellophane membrane 
(0.45 μm) previously soaked overnight in dissolution 
medium was mounted onto Franz diffusion cell with 
15 ml receptor compartment and effective diffusion area 
2.84 cm
2
. PBS (pH 7.4) was used as receptor medium, 
and system was thermostated to 37 ± 1°C under constant 
stirring. All batches of drug microsponge gels (F1–F10) 
were conducted for the diffusion study. Aliquots of 1 ml 
volume were withdrawn at specific time intervals by 
maintaining sink condition. Withdrawn aliquots were 
then diluted using receptor medium and analyzed by a 
UV spectrophotometer (Shimadzu 1601, Kyoto, Japan) 
at 260 nm against PBS pH 7.4. To reveal the drug 
release mechanism and contrast, release profiles 
disparities among formulations, data obtained from 
timely drug release were used. Further, release data were 
analyzed by means of diverse mathematical models to 
know release kinetics
18
.  
Accelerated stability studies  
According to an in vitro release profile F3 formulation 
was selected as optimized formulation and which was 
subjected to stability studies as per ICH. 5gm of gel was 
filled with collapsible aluminum tubes and kept at 5°C, 
25°C/60% RH, 30°C/65% RH and 40°C/75% RH for a 
period of three months. The samples were withdrawn at 
specific time intervals (15, 30, 60 and 90 days) and 
evaluated for physical appearance, pH, homogeneity, 
spreadability, viscosity and drug release profiles
19
. 
Drug release kinetics  
To analyze the mechanism of fluconazole release from 
the formulations, the in vitro release data were fitted 
into various release kinetic models. The models used 
are: zero order, first order, Higuchi model and 
Korsmeyer - Peppas. The model with the highest 
correlation coefficient was considered to be the best 
fitted model
20
. 
RESULTS AND DISCUSSIONS 
Formulation of Fluconazole microsponge 
Quasi-emulsion solvent diffusion method was used for 
the preparation of fluconazole microsponges and it has 
the following advantages like easy, rapid, cost effective 
and avoiding solvent toxicity
9
. Ethyl acetate and water 
were used as internal phase and external phases for the 
preparation of fluconazole microsponges. The drug and 
polymer solubility, rate of diffusion into the internal 
phase, were used to provide good spherical porous 
microsponges Figure1. 
 
 
Figure 1: Scaning Electron Microspcopy of 
Fluconazole loaded microsponge
 
Table 1: Composition of Fluconazole microsponges 
Ingredients Formulation batches of Fluconazole microsponge 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
D/P ratio 1:0.5 1:1 1:1.5 1:2 1:2.5 1:3 1:1.5 1:1.5 1:1.5 1:1.5 
Ethyl Acetate (ml) 10 10 10 10 10 10 10 10 10 10 
Tri ethyl citrate (ml) 1 1 1 1 1 1 1 1 1 1 
PVA (%w/v) 0.75 0.75 0.75 0.75 0.75 0.75 0.45 0.6 0.9 1 
Water (ml) 90 90 90 90 90 90 90 90 90 90 
D/P ratio = Drug: Polymer ratio, PVA=Poly vinyl alcohol 
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Fourier Transform Infrared studies  
The IR spectra of pure fluconazole and formulation are 
shown in Figure & Table.  The peak at 3120 cm-1 
indicate  O-H stretching, 3012 cm-1 for the C-H 
stretching, 1620 cm- 1 for the aromatic C=C stretching, 
1597 cm-1 for the N-H bending, 1354 cm-1 for the C-H 
bending. These are the major spectral peaks of the drug. 
All these peaks were present in the formulations and 
thus this confirms that the drug did not have any 
interaction with the excipients. Results are shown in 
Figures 2, 3 & Table 2 
 
 
Figure 2: FT-IR Spectra of Drug 
 
 
Figure 3: FT-IR Spectra of Drug +Ethyl cellulose and Poly vinyl alcoho 
 
Table 2: Relevant bands of drug & physical mixture in their FT-IR Spectra 
S.No Functional group Pure Drug Physical Mixture Type of vibration 
1 O-H 3120.82 3120.82 Stretching 
2 C-H 3012.61 3012.61 Stretching 
3 C=C Ar 1620.21 1620.21 Stretching 
4 N-H 1597.06 1597.06 Bending 
5 C-H 1354.03 1354.03 Bending 
 
Scanning electron microscopy  
The morphology of the prepared microsponges was 
studied by SEM analysis. The shape and surface 
characteristics of the microsponges are shown in Figure 
1. The microsponges were finely spherical and uniform 
in shape, highly porous in nature. The pores were 
created by the diffusion of solvent from surface of 
microsponges. The obtained SEM photograph was 
recorded at ×500 magnification. The captured images of 
microsponges are shown in Figure 4.  
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Figure 4: Scaning Electron Microspcopy Image of 
microsponge surface 
Production yield actual FLZ content, and 
entrapment efficiency (EE %) 
The effect of the D/P ratio of production yield, 
encapsulation efficiency and drug content are shown in 
Table. It revealed that drug encapsulation efficiency did 
not attain 100%, this might be due to fewer quantity of 
the drug gets dissolved in either phase. The production 
yield of all batches of fluconazole microsponges were 
ranged from 20.12% to 74.24%. The D/P ratio and PVA 
concentration were found to affect production yield 
significantly. A low production yield was noticed in a 
D/P ratio of 1:0.5 (F1), whereas, in D/P ratio 1:3 (F6) 
production yield was remarkably high i.e. 74.24%. The 
results indicated that higher the D/P ratio, higher the 
production yields. Besides this, the concentration of 
PVA also is equally responsible for production yield. 
Lower the PVA concentration, i.e. 0.45 %w/v yields less 
production 33.37% (F7) and as the concentration was 
increased to 0.9 (%w/v) the production yield was also 
found to be increased up to 51.64% (F8, F9). But in the 
case of (F10) less production yield was noticed, the 
reason is might be due to the presence of excessive 
amount of surfactant 1.0 %w/v it was responsible for 
more foam due to which less production yield was 
noticed 31.64% Rate of solvent diffusion from inner 
phase to outer phase took more time for formation of 
droplet and this might be the reason for high production 
yield. The encapsulation efficiencies were in the range 
of 64.12–91.35% as shown in Table 3. The outcome of 
encapsulation efficiency reflected that increasing the 
D/P ratios (F1-F6) led to decrease drug loadings. The 
results were depicted in Table 3. 
 
Table 3: Actual drug content, encapsulation efficiency and production yield 
Code D/P ratio Theoretical drug 
content (%) 
Actual drug 
content (%) ± SD 
Encapsulation 
efficiency (%) ± SD 
Production yield 
(%) ± SD 
F1 1:0.5 75 72.58±0.01 85.56±0.01 32.12±0.21 
F2 1:1 60 58.02±0.02 85.12±0.02 34.60±0.20 
F3 1:1.5 53 50.46±0.01 84.10±0.03 38.40±0.39 
F4 1:2 41 37.23±0.14 83.42±0.01 40.00±0.01 
F5 1:2.5 36 32.16±0.02 82.10±0.03 45.13±0.04 
F6 1:3 28 30.16±0.02 80.10±0.03 52.24±0.02 
F7 1:1.5 53 49.35±0.01 89.37±0.21 33.37±0.04 
F8 1:1.5 53 49.27±0.02 82.62±0.01 37.52±0.11 
F9 1:1.5 53 49.83±0.01 46.12±0.02 43.31±0.17 
F10 1:1.5 53 51.13±0.02 49.10±0.01 31.64±0.15 
 
Particle size  
The average particle size of microsponge formulations 
should be in the range of 5–300 µm. The Particle size 
distribution of F3 formulation has been performed by 
laser light-scattering technique a particle size 
distribution map by volume of the fluconazole 
microsponge was identified, which showed that the 
specific area surface diameter and diameter by volume 
of the particles were 0.19 m
2
/g, 30.22µm and 55.9 µm 
respectively. The particle size distribution of d (0.1), d 
(0.5) and d (0.9) were 17.27 µm, 47.49 µm and 108.6 
µm respectively and the uniformity was 0.587. Figure 5.
 
 
Figure 5:  Particle size distribution curve of microsponges of (Optimized batch) 
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Evaluation of fluconazole microsponge loaded 
carbopol gel 
Visual inspection 
The prepared fluconazole loaded microsponge gel 
formulations were inspected visually for their color, 
texture and appearance. All prepared formulations were 
White, viscous in nature with smooth texture and of 
good homogeneity without lumps  
pH measurement 
The pH values of all prepared formulations were found 
in the range of 6.5–7, this is due to neutralization of 
formula by tri ethanol amine. 
Spreadability test 
Spreadability is one of the important characteristic of 
topical formulations and it helps to transfer correct 
dosage to the target site and make ease of application. 
Fluconazole microsponge loaded carbopol 934 forms a 
gel with spreadability ranges between to 2.10- 4.38 
gcm/s. There was a slight decrease in spreading 
diameters of formulations of F4-F6; this variation was 
might be due to increased polymer concentration in 
microsponge. 
Viscosity measurement 
The viscosity of prepared fluconazole microsponge gel 
was measured in L4 Spindle Brookefield Viscometer, 
model- VL2, manufacturer Lemis Baltic and was found 
to be in the range 25030 cPs to 47390 cPs. The results 
were depicted in Table 4. 
 
Table 4: Physicochemical evaluation of fluconazole microsponge carbopol gel formulations 
Code Physical appearance pH  Spreadability Homogenesity Viscosity  
F1 Transparent gel 6.5±0.03 4.38±0.5 Homogeneous 25,030 
F2 Transparent gel 6.5±0.02 3.95±0.4 Homogeneous 29,630 
F3 Transparent gel 6.8±0.01 3.31±0.3 Homogeneous 34,520 
F4 Transparent gel 6.5±0.01 3.10±0.3 Homogeneous 38,630 
F5 Transparent gel 6.8±0.02 2.45±0.5 Homogeneous 40,630 
F6 Transparent gel 7.0±0.04 2.10±0.5 Homogeneous 47,390 
F7 Transparent gel 7.0±0.03 3.30±0.6 Homogeneous 33,820 
F8 Transparent gel 7.0±0.03 3.41±0.8 Homogeneous 33,620 
F9 Transparent gel 6.5±0.04 3.20±0.6 Homogeneous 34,500 
F10 Transparent gel 6.8±0.04 3.10±0.6 Homogeneous 34,540 
 
In vitro drug release study 
The in vitro dissolution profile was done for fluconazole 
microsponge formulas (F1-F10). From the in vitro 
release data it was noticed that the drug release was 
reduced from 94.10-42.70%, this is due to D/P ratio has 
increased i.e. the amount of polymer available was more 
in each formulation. It led to thickening of the polymer 
matrix wall, thus lesser drug release was occurring. 
94.10% of drug release was found in the highest drug 
release (F1) within 4Hrs, while the lowest 42.70% for 
F6 at the end of 8Hrs. It has been reported that by 
increasing the amount of PVA from batches F7 to F10, 
there was no significant change in the drug release 
pattern as compared with F3 formulation. Cumulative 
drug release of all batches F1–F6 and F7–F10 was 
shown in Figure 6, 7. According to in vitro release data 
formulation code F3 was selected as optimized batch.
 
 
Fig 6: Dissolution profile of Fluconazole from microsponge (F1–F6) 
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Figure 7: Dissolution profile of Fluconazole from microsponge (F7–F10) 
 
Table 5: Physicochemical evaluation of microzsponge loaded carbopol gel during stability period 
F.Code Appearance Homogenicity Spread ability Viscosity pH % drug release 
F3 White Homogeneous 3.31 34,480 6.8±0.01 73.0±0.01 
 
 
Drug release kinetics 
The drug release kinetic data are represented in Figure 
8-11. From the graphical representation it can be 
understood that this layer is best fit in to Zero order 
kinetics which had shown a regression coefficient (R
2
) 
of 0.9831.  
 
Figure 8: Zero order kinetic model     
 
Figure 9: First order kinetics model 
  
Figure 10: Korse meyer peppas kinetic model 
     
Figure 11: Higuchi kinetic model     
The results of the in vitro release data of this layer were 
fitted to the Korsemeyer-Peppas equation to analyze the 
release pattern of the drug from the polymeric system. 
The value of “n” was found to be more than 0.89, 
indicating the drug release follows super case II 
transport. 
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Stability study 
During stability studies, formulation was found to be a 
White, homogenous, smooth and no changes in pH. It 
was also noticed that there were no changes in 
spreadability but slight changes in viscosity and drug 
release. Therefore, drug degradation was not observed. 
From that above data it has been proved that the 
formulation was stable over the period of 3 months. The 
results were shown in Figure 12. 
 
Figure 12. Drug release profile of microsponge gel 
during stability study 
 
Effect of formulation variables 
Effect of external phase 
The concentration of emulsifier plays a vital role in the 
preparation of microsponges. The minimum 
concentration of emulsifier required to formation of 
uniform and stable microsponges was found to be 0.75% 
w/v of external phase. Almost, similar encapsulation 
efficiency was noticed formulation code F1-F6. When 
the concentration of emulsifier was decreased from 
0.75% to 0.45% (F7) production yield, encapsulation 
efficiency and drug content were increased and the 
formed microsponges were collapsed after 3 days figure 
13 & table 6.   Whereas irregular microsponges were 
formed in the concentration of 0.6% w/v of emulsifier 
figure 14 & table 6. When the concentration of 
emulsifier was increased to 0.9% and 1% w/v F9 & F10 
resulted in the more foam formation and it drastically 
affects production yield, encapsulation efficiency and 
drug release behavior. 
 
Table 6: Effect of external phase 
Code PVA Concentration in 
(mg) 
Production yield 
(%) ± SD 
Encapsulation 
efficiency (%) ± SD 
% CDR ± SD 
F3 0.75 38.40±0.39 84.10±0.03 74.2±0.46 
F7 0.45 77.61±0.02 89.37±0.21 73.7±0.29 
F8 0.60 37.52±0.11 82.62±0.01 71.4±0.23 
F9 0.90 23.31±0.17 46.12±0.02 68.1±0.27 
F10 1.00 21.64±0.15 49.10±0.01 66.2±0.32 
 
 
 
 
Figure 13: Microsponges at 0.45% concentration of 
PVA 
 
Figure 14: Formation of irregular microsponge using 
0.6% concentration of PVA 
Effect of D/P ratio 
Increase in D/P ratio has been found to result an increase 
in production yield; while drug content, encapsulation 
efficiency and percent drug release were found to be 
decreased Table 7. The reason behind that is as D/P ratio 
went on increasing, the polymer amount available for 
each microsponge to encapsulate the drug was more, 
thus rising polymer matrix wall thickness which led to 
an extended diffusion path and ultimately to lesser drug 
release
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Table 7: Effect of D/P ratio 
Code D/P ratio Production yield 
(%) ± SD 
Drug 
content(%) ± SD 
Encapsulation 
efficiency (%) ± SD 
 
% CDR ± SD 
F1 1:0.5 32.12±0.21 72.58±0.01 85.56±0.01 94.1±0.01 
F2 1:1 34.60±0.20 58.02±0.02 85.12±0.02 85.1±0.01 
F3 1:1.5 38.40±0.39 50.46±0.01 84.10±0.03 74.2±0.02 
F4 1:2 40.00±0.01 37.23±0.14 83.42±0.01 65.1±0.01 
F5 1:2.5 45.13±0.04 32.16±0.02 82.10±0.03 52.8±0.03 
F6 1:3 52.24±0.02 30.16±0.02 80.10±0.03 42.7±0.02 
 
CONCLUSION 
Microsponge-based novel delivery system has been 
developed to provide once a day sustained release 
medication for topical delivery of fluconazole. The 
method adopted was quasi-emulsion solvent diffusion; 
found to be simple, reproducible and rapid. Formed 
microsponges were spherical shape, have high porosity. 
Different drug–polymer ratio reflected good particle size, 
drug content and encapsulation efficiency. Microsponge-
based gel showed viscous and homogenizes preparation 
and in vitro drug release reflected highest regression 
value for zero order release model.Microsponge 
formulated with 1:1.5 drug–polymer ratios were found 
more efficient to give an extended drug release 74.20% at 
the end of 8h. Gel containing microsponges prepared in 
this study was found to be promising as new-novel 
delivery system offering prolonged release of fluconazole 
in treating fungal infections. 
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